Advertisement
DALLAS, Feb. 12, 2015 /PRNewswire-iReach/ -- The new report Active Pharmaceutical Ingredients (API) Market in US says the strong focus on the development and introduction of the high - potency API is one major trend upcoming in the market. Such products are increasingly used in oncology and for the provision of targeted therapy. As Aceto is a high quality intermediates it has become a key component of all drugs, whether they are already on the market or currently undergoing clinical trials.
Photo - http://photos.prnewswire.com/prnh/20150212/175201
The key vendors in the Active Pharmaceutical Ingredients (API) Market in the US are expected to focus more on the development and commercialization of high-potency API in the coming years. Demand for these products is substantial and is expected to be strong during the forecast period because of an increase in the application of targeted therapy for the treatment of diseases.
To remain competitive vendors are showing interest in technological collaborations and R&D alliances. The report recognizes the following companies as the key players in the API Market in the US: Abbott Laboratories, Aurobindo Pharma Ltd., Mylan Inc. and Teva Pharmaceutical Industries Ltd.
Other Prominent Vendors in the market are: Albemarle, Aptuit, BASF, Biocon, Boehringer Ingelheim, Cambrex, Cipla, Dr. Reddy's Laboratories, Hospira, Lonza Group, Novartis, Pfizer, Sigma-Aldrich and Sun Pharmaceutical Industries.
Analysts forecast the Active Pharmaceutical Ingredients (API) Market in the US to grow at a CAGR of 7.01% over the period 2014-2019. According to the report, one of the key drivers contributing to the growth of the API market in the US is the strong preference for generic drugs compared with innovative or branded drugs. The use of generic equivalents is preferred to innovative drugs, with countries encouraging doctors and pharmacists to prescribe such equivalents.
Order a copy of this report at (Prices start at US $ 2500 for a single user PDF) http://www.reportsnreports.com/purchase.aspx?name=344068.
Vendors are required to comply with elaborate procedures prior to product commercialization. For instance, compliance with GMP requirements increases costs for vendors.
A Global Active Pharmaceutical Ingredients Market 2015-2019 is also available, that profile players, from global market - the key players in the Global Active Pharmaceutical Ingredients Market: Aurobindo Pharma Ltd., BASF SE, Boehringer Ingelheim GmbH, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Lonza Group and Teva Pharmaceutical Industries Ltd.
Other Prominent Vendors in the market are: Abbott Laboratories, Actavis, Aesica, Albemarle, AMPAC Fine Chemicals, Anhui Biochem United Pharmaceutical, Anuh Pharma, Aptuit, AstraZeneca, Biocon, Bristol-Myers Squibb, Calyx Chemicals and Pharmaceuticals, Cambrex, Cilag, CIRON Drugs and Pharmaceuticals, CTX Life Sciences, Dishman Pharmaceuticals and Chemicals, Dr. Paul Lohmann, Emcure Pharmaceuticals, Farmabios, F-Hoffman-La Roche, GlaxoSmithKline, Guilin Pharmaceutical, Hetero Drugs, Hospira, Ipca Laboratories, Janssesn Pharmaceutica, Johnson Matthey, Laurus Labs, Lupin, Mallinckrodt Pharmaceuticals, Mangalam Drugs and Organics, Merck, Mylan, Novartis, Novasep, Pen Tsao Chemical Industry, Pfizer, Ranbaxy Laboratories, Royal DSM, Sanofi-Aventis, Sequent Scientific, Shanghai Desano Chemical Pharmaceutical, Shasun, Shijiazhuang Lonzeal Pharmaceutical, Sigma-Aldrich, ST Pharm, Sun Pharmaceutical Industries, Wuxi Apptec, Zhejiang Langhua Pharmaceutical and Zhuhai Rundu Pharmaceutical.
Explore other new reports on Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.
About US
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email, the details on sales at reportsandreports.com.
Media Contact: Ritesh Tiwari, ReportsnReports, + 1 888 391 5441, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE ReportsnReports
Advertisement
Photo - http://photos.prnewswire.com/prnh/20150212/175201
The key vendors in the Active Pharmaceutical Ingredients (API) Market in the US are expected to focus more on the development and commercialization of high-potency API in the coming years. Demand for these products is substantial and is expected to be strong during the forecast period because of an increase in the application of targeted therapy for the treatment of diseases.
To remain competitive vendors are showing interest in technological collaborations and R&D alliances. The report recognizes the following companies as the key players in the API Market in the US: Abbott Laboratories, Aurobindo Pharma Ltd., Mylan Inc. and Teva Pharmaceutical Industries Ltd.
Other Prominent Vendors in the market are: Albemarle, Aptuit, BASF, Biocon, Boehringer Ingelheim, Cambrex, Cipla, Dr. Reddy's Laboratories, Hospira, Lonza Group, Novartis, Pfizer, Sigma-Aldrich and Sun Pharmaceutical Industries.
Analysts forecast the Active Pharmaceutical Ingredients (API) Market in the US to grow at a CAGR of 7.01% over the period 2014-2019. According to the report, one of the key drivers contributing to the growth of the API market in the US is the strong preference for generic drugs compared with innovative or branded drugs. The use of generic equivalents is preferred to innovative drugs, with countries encouraging doctors and pharmacists to prescribe such equivalents.
Order a copy of this report at (Prices start at US $ 2500 for a single user PDF) http://www.reportsnreports.com/purchase.aspx?name=344068.
Vendors are required to comply with elaborate procedures prior to product commercialization. For instance, compliance with GMP requirements increases costs for vendors.
A Global Active Pharmaceutical Ingredients Market 2015-2019 is also available, that profile players, from global market - the key players in the Global Active Pharmaceutical Ingredients Market: Aurobindo Pharma Ltd., BASF SE, Boehringer Ingelheim GmbH, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Lonza Group and Teva Pharmaceutical Industries Ltd.
Other Prominent Vendors in the market are: Abbott Laboratories, Actavis, Aesica, Albemarle, AMPAC Fine Chemicals, Anhui Biochem United Pharmaceutical, Anuh Pharma, Aptuit, AstraZeneca, Biocon, Bristol-Myers Squibb, Calyx Chemicals and Pharmaceuticals, Cambrex, Cilag, CIRON Drugs and Pharmaceuticals, CTX Life Sciences, Dishman Pharmaceuticals and Chemicals, Dr. Paul Lohmann, Emcure Pharmaceuticals, Farmabios, F-Hoffman-La Roche, GlaxoSmithKline, Guilin Pharmaceutical, Hetero Drugs, Hospira, Ipca Laboratories, Janssesn Pharmaceutica, Johnson Matthey, Laurus Labs, Lupin, Mallinckrodt Pharmaceuticals, Mangalam Drugs and Organics, Merck, Mylan, Novartis, Novasep, Pen Tsao Chemical Industry, Pfizer, Ranbaxy Laboratories, Royal DSM, Sanofi-Aventis, Sequent Scientific, Shanghai Desano Chemical Pharmaceutical, Shasun, Shijiazhuang Lonzeal Pharmaceutical, Sigma-Aldrich, ST Pharm, Sun Pharmaceutical Industries, Wuxi Apptec, Zhejiang Langhua Pharmaceutical and Zhuhai Rundu Pharmaceutical.
Explore other new reports on Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.
About US
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email, the details on sales at reportsandreports.com.
Media Contact: Ritesh Tiwari, ReportsnReports, + 1 888 391 5441, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE ReportsnReports
